Shares of Meta Material, formerly Torchlight, rise 6%

Selpercatinib is the first drug from Loxo’s pipeline that Lilly has brought to market. Prior to the acquisition, Loxo won approval of Vitrakvi, which targets a different genetic mutation and is sold by Bayer AG. Although the company will continue to pursue “higher-risk, high reward” drug candidates such as pegilodecakin,…

US STOCKS-S&P futures stall at all-time high

Flashpoint Batley: Anti-racism protesters hold rally against… Flair also analysed dozens of open letters published by alumnae of private schools who complained last year about racist abuse they had endured in schools and a lack of black role models among teachers. Nicholas Hewlett, head of St Dunstan’s College private school…